127 related articles for article (PubMed ID: 16319328)
1. Choice of endogenous control for gene expression in nonsmall cell lung cancer.
Liu DW; Chen ST; Liu HP
Eur Respir J; 2005 Dec; 26(6):1002-8. PubMed ID: 16319328
[TBL] [Abstract][Full Text] [Related]
2. Real-time RT-PCR for the detection of beta-adrenoceptor messenger RNAs in small human endomyocardial biopsies.
Moniotte S; Vaerman JL; Kockx MM; Larrouy D; Langin D; Noirhomme P; Balligand JL
J Mol Cell Cardiol; 2001 Dec; 33(12):2121-33. PubMed ID: 11735259
[TBL] [Abstract][Full Text] [Related]
3. The methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significance.
Nakata S; Sugio K; Uramoto H; Oyama T; Hanagiri T; Morita M; Yasumoto K
Cancer; 2006 May; 106(10):2190-9. PubMed ID: 16598757
[TBL] [Abstract][Full Text] [Related]
4. P53 and K-ras mutations are frequent events in microscopically negative surgical margins from patients with nonsmall cell lung carcinoma.
Jassem J; Jassem E; Jakóbkiewicz-Banecka J; Rzyman W; Badzio A; Dziadziuszko R; Kobierska-Gulida G; Szymanowska A; Skrzypski M; Zylicz M
Cancer; 2004 May; 100(9):1951-60. PubMed ID: 15112277
[TBL] [Abstract][Full Text] [Related]
5. Decreased fragile histidine triad gene messenger RNA expression in lung cancer.
Sasaki H; Haneda H; Yukiue H; Kobayashi Y; Yano M; Fujii Y
Clin Lung Cancer; 2006 May; 7(6):412-6. PubMed ID: 16800968
[TBL] [Abstract][Full Text] [Related]
6. Exclusive mutation in epidermal growth factor receptor gene, HER-2, and KRAS, and synchronous methylation of nonsmall cell lung cancer.
Suzuki M; Shigematsu H; Iizasa T; Hiroshima K; Nakatani Y; Minna JD; Gazdar AF; Fujisawa T
Cancer; 2006 May; 106(10):2200-7. PubMed ID: 16598760
[TBL] [Abstract][Full Text] [Related]
7. Optimization of quantitative real-time RT-PCR parameters for the study of lymphoid malignancies.
Lossos IS; Czerwinski DK; Wechser MA; Levy R
Leukemia; 2003 Apr; 17(4):789-95. PubMed ID: 12682639
[TBL] [Abstract][Full Text] [Related]
8. Reduced XPC messenger RNA level may predict a poor outcome of patients with nonsmall cell lung cancer.
Wu YH; Cheng YW; Chang JT; Wu TC; Chen CY; Lee H
Cancer; 2007 Jul; 110(1):215-23. PubMed ID: 17508409
[TBL] [Abstract][Full Text] [Related]
9. Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression.
Vonlanthen S; Heighway J; Tschan MP; Borner MM; Altermatt HJ; Kappeler A; Tobler A; Fey MF; Thatcher N; Yarbrough WG; Betticher DC
Oncogene; 1998 Nov; 17(21):2779-85. PubMed ID: 9840942
[TBL] [Abstract][Full Text] [Related]
10. Expression of pigment epithelial derived factor is reduced in non-small cell lung cancer and is linked to clinical outcome.
Zhang L; Chen J; Ke Y; Mansel RE; Jiang WG
Int J Mol Med; 2006 May; 17(5):937-44. PubMed ID: 16596284
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
[TBL] [Abstract][Full Text] [Related]
12. [Novel reference gene RPN1 for normalization of quantitative data in lung and kidney cancer].
Krasnov GS; Oparina NIu; Dmitriev AA; Kudriavtsev AV; Anedchenko EA; Kondrat'eva TT; Zabarovskiĭ ER; Senchenko VN
Mol Biol (Mosk); 2011; 45(2):238-48. PubMed ID: 21634111
[TBL] [Abstract][Full Text] [Related]
13. Expression of MMP-10 in lung cancer.
Zhang X; Zhu S; Luo G; Zheng L; Wei J; Zhu J; Mu Q; Xu N
Anticancer Res; 2007; 27(4C):2791-5. PubMed ID: 17695449
[TBL] [Abstract][Full Text] [Related]
14. Frequent epigenetic inactivation of deleted in lung and esophageal cancer 1 gene by promoter methylation in non-small-cell lung cancer.
Zhang Y; Miao Y; Yi J; Wang R; Chen L
Clin Lung Cancer; 2010 Jul; 11(4):264-70. PubMed ID: 20630829
[TBL] [Abstract][Full Text] [Related]
15. Protein overexpression and gene amplification of epidermal growth factor receptor in nonsmall cell lung carcinomas. An immunohistochemical and fluorescence in situ hybridization study.
Suzuki S; Dobashi Y; Sakurai H; Nishikawa K; Hanawa M; Ooi A
Cancer; 2005 Mar; 103(6):1265-73. PubMed ID: 15712203
[TBL] [Abstract][Full Text] [Related]
16. Smoking and cancer-related gene expression in bronchial epithelium and non-small-cell lung cancers.
Woenckhaus M; Klein-Hitpass L; Grepmeier U; Merk J; Pfeifer M; Wild P; Bettstetter M; Wuensch P; Blaszyk H; Hartmann A; Hofstaedter F; Dietmaier W
J Pathol; 2006 Oct; 210(2):192-204. PubMed ID: 16915569
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous measurement of MMP9 and TIMP1 mRNA in human non small cell lung cancers by multiplex real time RT-PCR.
Simi L; Andreani M; Davini F; Janni A; Pazzagli M; Serio M; Orlando C
Lung Cancer; 2004 Aug; 45(2):171-9. PubMed ID: 15246188
[TBL] [Abstract][Full Text] [Related]
18. Identification of accurate reference genes for RT-qPCR analysis of formalin-fixed paraffin-embedded tissue from primary non-small cell lung cancers and brain and lymph node metastases.
Søes S; Sørensen BS; Alsner J; Overgaard J; Hager H; Hansen LL; Kristensen LS
Lung Cancer; 2013 Aug; 81(2):180-6. PubMed ID: 23643276
[TBL] [Abstract][Full Text] [Related]
19. Regulation of hypoxanthine phosphoribosyltransferase, glyceraldehyde-3-phosphate dehydrogenase and beta-actin mRNA expression in porcine immune cells and tissues.
Foss DL; Baarsch MJ; Murtaugh MP
Anim Biotechnol; 1998; 9(1):67-78. PubMed ID: 9676236
[TBL] [Abstract][Full Text] [Related]
20. Prostacyclin synthase expression and epigenetic regulation in nonsmall cell lung cancer.
Cathcart MC; Gray SG; Baird AM; Boyle E; Gately K; Kay E; Cummins R; Pidgeon GP; O'Byrne KJ
Cancer; 2011 Nov; 117(22):5121-32. PubMed ID: 21523772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
